Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: The study was conducted according to the appropriate OECD test guideline, and in compliance with GLP.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2013
Report date:
2013

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Version / remarks:
1997
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
Version / remarks:
2008
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Cyclohexanethiol
EC Number:
216-378-7
EC Name:
Cyclohexanethiol
Cas Number:
1569-69-3
Molecular formula:
C6H12S
IUPAC Name:
cyclohexanethiol
Test material form:
other: liquid

Method

Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
Metabolic activation:
with and without
Metabolic activation system:
phenobarbital and ß-naphthoflavone induced rat liver S9
Test concentrations with justification for top dose:
Expt 1: 3, 10, 33, 100, 333, 1000, 3330, 5000 μg/plate; Expt 2: 3, 10, 33, 100, 333, 1000 μg/plate
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO.
- Justification for choice of solvent/vehicle: none given in study report.
- Since the test substance is reactive to oxygen, the test substance was flushed with nitrogen after weighing, and the test substance concentrations were prepared within 0.5 hour and used in the experiment within 1.5 hours.
Controlsopen allclose all
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
sodium azide
Remarks:
TA1535 (5 μg) without metabolic activation
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
2-nitrofluorene
Remarks:
TA1537 (15 μg) and T98 (10 μg) without metabolic activation
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
methylmethanesulfonate
Remarks:
TA 100 (650 μg) without metabolic activation
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
4-nitroquinoline-N-oxide
Remarks:
WP2uvrA (10 μg) without metabolic activation
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: 2-aminoanthracene
Remarks:
All strains with metabolic activation
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation); preincubation;

DURATION
- Preincubation period: 30 minutes
- Exposure duration: 48 hours

SELECTION AGENT (mutation assays): histidine and tryptophan deficient agar.

NUMBER OF REPLICATIONS: Each concentration was tested in triplicate and the experiment was repeated. The dose range-finding experiment was reported as a part of the first experiment of the mutation assay.

DETERMINATION OF CYTOTOXICITY
- Method: other: condition of background lawn; number and size of revertant colonies

OTHER:
METABOLIC ACTIVATION
Before use, all S9 batches were characterised with the mutagens Benzo-(a)-pyrene (Sigma) and
2-aminoanthracene, which require metabolic activation, in tester strain TA98 at concentrations of 5 μg/plate and 1 μg/plate, respectively.
S9 mix contained 5% (v/v) S9-fraction), and the following per 10 ml: 30 mg NADP and 15.2 mg glucose-6-phosphate in 5.5 ml or 5.0 ml Milli-Q water (first or second experiment respectively); 2 ml 0.5 M sodium phosphate buffer pH 7.4; 1 ml 0.08 M MgCl2 solution; 1 ml 0.33 M KCl solution.
Evaluation criteria:
A substance is considered positive if a) The total number of revertants in tester strain TA100 is greater than two (2) times the concurrent control, or the total number of revertants in tester strains TA1535, TA1537, TA98 or WP2uvrA is greater than three (3) times the concurrent control; b) The increase in the number of revertants is reproducible.

Results and discussion

Test results
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
333 μg/plate
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: no precipitation observed

RANGE-FINDING/SCREENING STUDIES: results reported as experiment 1

COMPARISON WITH HISTORICAL CONTROL DATA: The negative and strain-specific positive control values were within the laboratory historical control data ranges.

ADDITIONAL INFORMATION ON CYTOTOXICITY: Background lawn condition and existence of microcolonies were observed at 333 and 1000 μg/plate.
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Any other information on results incl. tables

Table 2 Experiment 1 (pre-incubation). Mean number of revertant colonies/3 replicate plates (± S.D.)

Dose (μg/plate)

TA1535

TA1537

TA98

TA100

WP2uvrA

Without metabolic activation

positive control

 721 ± 65

 608 ± 87

 826 ± 14

 927 ± 19

 498 ± 27

solvent control

 10 ± 4

 4 ± 1

 20 ± 1

 103 ± 2

 34 ± 11

3

 7 ± 2

 4 ± 2

 12 ± 1

 109 ± 12

 51 ± 25

10

 5 ± 2

 1 ± 1

 19 ± 6

108 ± 14

 35 ± 4

33

 10 ± 4

 3 ± 1

 19 ± 3

97 ± 13

 49 ± 12

100

 7 ± 4

 3 ± 1

 8 ± 1

117 ± 8

 42 ± 4

333

 4 ± 2 m

 3 ± 1

 5 ± 7 m

101

 32 ± 0

1000

 MC e

 MC e

 2 ± 3 e

 MC e

 MC e

 3330

-

-

-

MC e

MC e

With metabolic activation1

positive control

 310 ± 14

 373 ± 30

 845 ± 56

 1041 ± 38

 362 ± 14

solvent control

 4 ± 0

 2 ± 2

 52 ± 8

 101 ± 8

 36 ± 5

3

 8 ± 4

 4 ± 0

 41 ± 5

 99 ± 8

 37 ± 6

10

 7 ± 3

 4 ± 0

 39 ± 9

 96 ± 2

 44 ± 8

33

 8 ± 2

 4 ± 2

 44 ± 3

 99 ± 11

 41 ± 5

100

 8 ± 3

 3 ± 1

 44 ± 4

 111 ± 3

 28 ± 5

333

 5 ± 1

 4 ± 1

 MC e

 84 ± 8

 41 ± 8

1000

 MC e

 MC e

 MC e

 MC e

 MC e

3330

 -

-

-

  MC e

  MC e

5000

 -

-

-

  MC e

  MC e

 

Table 3 Experiment 2 (pre-incubation). Mean number of revertant colonies/3 replicate plates (± S.D.)

Dose (μg/plate)

TA1535

TA1537

TA98

TA100

WP2uvrA

Without metabolic activation

positive control

 775 ± 12

 214 ± 25

 826 ± 14

 752 ± 87

 697 ± 41

solvent control*

 6 ± 3

 7 ± 3

 15 ± 1

 136 ± 6

 26 ± 3

3

 13 ± 5

 5 ± 3

 16 ± 2

 122 ± 16

 27 ± 3

10

 9 ± 3

 3 ± 3

 14 ± 4

 125 ± 16

 28 ± 3

33

 11 ± 1

 4 ± 2

 11 ± 2

 123 ± 7

 30 ± 3

100

 7 ± 2

 3 ± 0

 14 ± 5

 115 ± 18

 24 ± 7

333

 5 ± 2 m

 2 ± 3 s

 10 ± 2 m

 71 ± 12 m

 23 ± 3

1000

 12 ± 3 m

 2 ± 1 e

 MC e

 MC e

 7 ± 4 m

With metabolic activation2

positive control

 191 ± 20

 268 ± 55

 272 ± 17

 631 ± 121

 146 ± 24

solvent control*

 5 ± 1

 3 ± 1

 20 ± 4

 75 ± 20

 32 ± 3

3

 9 ± 4

 3 ± 1

 14 ± 3

 109 ± 2

 36 ± 3

10

 9 ± 1

 3 ± 2

 19 ± 5

 97 ± 7

 34 ± 5

33

 10 ± 3

 4 ± 2

 20 ± 8

 95 ± 17

 33 ± 5

100

 8 ± 1

 2 ± 0

 19 ± 5

 92 ± 11

 36 ± 2

333

 10 ± 3 s

 4 ± 1

 22 ± 5

 81 ± 19 s

 32 ± 9

1000

 MC ± m

 MC e

 MC e

 MC e

 MC m

Solvent control: 0.1 ml dimethyl sulfoxide

1 The S9-mix contained 5% (v/v) S9 fraction

2 The S9-mix contained 10% (v/v) S9 fraction

m Bacterial background lawn moderately reduced

e Bacterial background lawn extremely reduced

MC Microcolonies

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative with and without metabolic activation

Cyclohexylmercaptan has been tested for mutagenicity in a reliable study conducted according to OECD 471 and in compliance with GLP. No increase in the number of revertant colonies was observed when the substance was tested up to cytotoxic concentrations in Salmonella typhimurium strains TA 98, TA 100, TA 1535, TA1537 and Escherichia coli WP2 uvrA, in the presence and absence of metabolic activation. The study was conducted using the pre-incubation method, and was repeated to confirm the negative result. Appropriate positive and solvent controls were included and gave expected results. It is concluded that the test substance is negative for mutagenicity to bacteria under the conditions of the test.